March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
The Role Of CC Chemokines And Their Receptors In The Retinal Degeneration In Rd Mice
Author Affiliations & Notes
  • Huiyang Zeng
    Being Tongren Eye Center, Beijing Tongren Hosp, Capital Med Univ, Beijing, China
  • Qian Liu
    Being Tongren Eye Center, Beijing Tongren Hosp, Capital Med Univ, Beijing, China
  • Qing-jun Lu
    Being Tongren Eye Center, Beijing Tongren Hosp, Capital Med Univ, Beijing, China
  • Ke-gao Liu
    Being Tongren Eye Center, Beijing Tongren Hosp, Capital Med Univ, Beijing, China
  • Ning-li Wang
    Being Tongren Eye Center, Beijing Tongren Hosp, Capital Med Univ, Beijing, China
  • Footnotes
    Commercial Relationships  Huiyang Zeng, None; Qian Liu, None; Qing-jun Lu, None; Ke-gao Liu, None; Ning-li Wang, None
  • Footnotes
    Support  from National natural science foundation of China
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 1656. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Huiyang Zeng, Qian Liu, Qing-jun Lu, Ke-gao Liu, Ning-li Wang; The Role Of CC Chemokines And Their Receptors In The Retinal Degeneration In Rd Mice. Invest. Ophthalmol. Vis. Sci. 2012;53(14):1656.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Our previous studies showed that CC chemokines and CCR1,one of the CC chemokine receptors, were involved in the retinal degeneration in the rd mice. The aim of current study was to further investigate the expression of CC chemokines and their other receptors in the rd retina and explore their role in the photoreceptor degeneration.

Methods: : Expression levels of CC chemokine receptors transcripts including CCR2,CCR3 and CCR5 in the whole retina in the control and rd mice at postnatal days (P) 8,10,12,14,16 and 18 were determined by RT-PCR assay. Location of CC chemokines including MCP-1,MCP-3, MIP-1a,MIP-1βand RANTES and their above receptors were studied by immunohistochemical analysis. Expression of gp91phox and iNOS in the rd retina at each age group was studied by real-time PCR analysis and immunostaining. Cellular location of CCR5, iNOS and gp91phox in the retina was determined by double labeling.

Results: : CCR3 and CCR5 mRNA was significantly up-regulated in the rd retina from P12 to P16 while CCR2 mRNA was down-regulated when compared with the controls. RANTES immunoreactivity was seen on the CD11b-postive retinal microglial cells while other CC chemokines were expressed in the neurons of inner retina. Immunoreactivity of CCR5 on the activated retinal microglial cells were found to be increased in the rd mice. CCR2 and CCR3 were expressed on the neurons in the inner retina of rd and control mice. Expression of gp91phox and iNOS transcripts began to increase in the rd retinas at P10d and P8d respectively, reached peak at P12d and maintained a high level until P16d. In the rd retina, immunoreactivity of gp91phox was observed on the microglial cells while iNOS was observed on the photoreceptor cells. Part of gp91phox and iNOS were co-localized with CCR5 and CCR1 (expressed on the photoreceptor as shown in our published study) respectively.

Conclusions: : Activation of CC chemokines receptors, especially CCR5 and CCR1, as well as activation of oxidative markers on the same cell type, were correlated with or precedes the occurrence (P10) and peak (P16) of photoreceptor apoptosis, suggesting that CC chemokines may play a role in the retinal degeneration in rd mice either indirectly through activation of microglial cells killing mechanism( activation of CCR5) or directly through activation of chemokine receptors (CCR1) on photoreceptor cells.

Keywords: retinal degenerations: hereditary • inflammation • cytokines/chemokines 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×